Jocasta is an Epidemiologist and Health Services Researcher and is an emerging leader in the field of cardiovascular research. Jocasta has expertise in atrial fibrillation (AF), acute cardiovascular events (cardiac arrest, myocardial infarction), disease management, and improving effectiveness and efficiency of health services. Jocasta completed a PhD at Monash University in the School of Public Health and Preventive Medicine for which she was awarded the School of Public Health and Preventive Medicine PhD Thesis Excellence Award 2014 for “an outstanding PhD thesis and its contribution to research”. Jocasta has overseen cardiac registries and has expertise in data linkage and analysis of large datasets. Dr Ball has >50 publications in leading peer-reviewed journals such as The Lancet, BMJ, Circulation and European Heart Journal. Dr Ball is Senior Research Fellow within the Centre of Cardiovascular Research and Education in Therapeutics (CCRET), Monash University, conducting research using major prehospital and hospital cardiac registries, linked data, and clinical trials. Jocasta also holds additional appointments at Baker Heart and Diabetes Institute (Honorary Senior Research Fellow), University of Melbourne (Honorary Research Fellow), and Torrens University (Adjunct Professor). Jocasta is a member of an international cardiovascular epidemiology collaboration at UiT-The Arctic University of Norway where she is a Visiting Academic. In addition, Jocasta is an international partner and network member of the Norwegian Atrial Fibrillation Research Network (afib.no). Jocasta’s research has been highly cited including in Austrlaian Government reports, national and international cardiovascular management guidelines and expert consensus statements). Jocasta continues to highlight the evolving burden of cardiac disease, both globally and in Australia. Notably, the primary outcome of the randomised controlled trial at the centre of Jocasta’s PhD (the SAFETY Trial) was published in The Lancet.